Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation.

Mason, Bethany

Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. [electronic resource] - Cellular and molecular life sciences : CMLS Jul 2020 - 2605-2620 p. digital

Publication Type: Journal Article

1420-9071

10.1007/s00018-019-03306-y doi


Acetylglucosamine--metabolism
Breast Neoplasms--enzymology
Cell Line, Tumor
DNA Breaks
F-Box Proteins--genetics
Female
HEK293 Cells
Humans
Phosphorylation
Protein Processing, Post-Translational
Sequence Deletion
Ubiquitin-Protein Ligases--metabolism
Ubiquitination